retatrutide glucagon Research Guide: What the Phase 2 Trial Data Reported (2026) I am extremely excited about
Description
What it Does, GLP-1 for Weight Loss Our unique formula doubles your GLP-1 levels in one use, curbs cravings and appetite, and debloats in 30 minutes
Which is what brings us to microdosing
Bae CS, Song J
Muscle loss is the primary nutritional risk
Retatrutide's diabetes relevance comes from its incretin and glucagon receptor profile
Securing supply for these blockbusters has been high on the agenda for both Eli Lilly and fellow GLP-1 developers, including Novo Nordisk, which reported 2023 sales from its own diabetes and weight loss semuglatide products Ozempic and Wegovy of $13.7 billion and $4.5 billion, respectively
